VP, Head of preclinical R&D and QC
Maria Habel studied biochemistry and received her Ph.D. in Science from the Graduate School for Cellular and Biomedical Science of the University Bern, Switzerland, in 2008. She joined InflaRx in 2008 as Head of Laboratory and was part of the initial InflaRx team to start the company. Dr. Habel has lead all pre-clinical R&D monoclonal antibody-related programs of InflaRx since 2013 and has taken on responsibilities for various scientific projects investigating the complement system and characterization of lead drug candidates. In addition, Dr. Habel oversees the manufacturing of the monoclonal antibodies, and has been appointed as Head of Quality Control within the company’s GMP manufacturing activities, since 2010.
